These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Caffeine inhibits antinociception by acetaminophen in the formalin test by inhibiting spinal adenosine A₁ receptors. Sawynok J; Reid AR Eur J Pharmacol; 2012 Jan; 674(2-3):248-54. PubMed ID: 22085758 [TBL] [Abstract][Full Text] [Related]
5. Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice. Dall'Igna OP; Fett P; Gomes MW; Souza DO; Cunha RA; Lara DR Exp Neurol; 2007 Jan; 203(1):241-5. PubMed ID: 17007839 [TBL] [Abstract][Full Text] [Related]
6. Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Huang ZL; Qu WM; Eguchi N; Chen JF; Schwarzschild MA; Fredholm BB; Urade Y; Hayaishi O Nat Neurosci; 2005 Jul; 8(7):858-9. PubMed ID: 15965471 [TBL] [Abstract][Full Text] [Related]
7. The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors. El Yacoubi M; Ledent C; Ménard JF; Parmentier M; Costentin J; Vaugeois JM Br J Pharmacol; 2000 Apr; 129(7):1465-73. PubMed ID: 10742303 [TBL] [Abstract][Full Text] [Related]
8. Role of caffeine in combined analgesic drugs from the point of view of experimental pharmacology. Engelhardt G; Mauz AB; Pairet M Arzneimittelforschung; 1997 Aug; 47(8):917-27. PubMed ID: 9296278 [TBL] [Abstract][Full Text] [Related]
9. Caffeine inhibition of rat carotid body chemoreceptors is mediated by A2A and A2B adenosine receptors. Conde SV; Obeso A; Vicario I; Rigual R; Rocher A; Gonzalez C J Neurochem; 2006 Jul; 98(2):616-28. PubMed ID: 16805851 [TBL] [Abstract][Full Text] [Related]
10. Effects of acetylsalicylic acid, paracetamol and caffeine and a combination of these substances on kidney glutathione levels. Engelhardt G; Homma D Arzneimittelforschung; 1996 May; 46(5):513-8. PubMed ID: 8737638 [TBL] [Abstract][Full Text] [Related]
11. Caffeine and a selective adenosine A(2B) receptor antagonist but not imidazoline receptor antagonists modulate antinociception induced by diphenyl diselenide in mice. Savegnago L; Jesse CR; Nogueira CW Neurosci Lett; 2008 May; 436(2):120-3. PubMed ID: 18375062 [TBL] [Abstract][Full Text] [Related]
12. Adenosine receptors involved in modulation of noradrenaline release in isolated rat tail artery. Diniz C; Fresco P; Leal S; Gonçalves J Eur J Pharmacol; 2004 Nov; 504(1-2):17-25. PubMed ID: 15507216 [TBL] [Abstract][Full Text] [Related]
13. Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability. Yan L; Müller CE J Med Chem; 2004 Feb; 47(4):1031-43. PubMed ID: 14761205 [TBL] [Abstract][Full Text] [Related]
14. Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol. Sandrini M; Pini LA; Vitale G Inflamm Res; 2003 Aug; 52(8):347-52. PubMed ID: 14504673 [TBL] [Abstract][Full Text] [Related]
15. The effect of paracetamol on nociception and dynorphin A levels in the rat brain. Sandrini M; Romualdi P; Capobianco A; Vitale G; Morelli G; Pini LA; Candeletti S Neuropeptides; 2001 Apr; 35(2):110-6. PubMed ID: 11384206 [TBL] [Abstract][Full Text] [Related]
16. Caffeine reduces hypnotic effects of alcohol through adenosine A2A receptor blockade. El Yacoubi M; Ledent C; Parmentier M; Costentin J; Vaugeois JM Neuropharmacology; 2003 Dec; 45(7):977-85. PubMed ID: 14573390 [TBL] [Abstract][Full Text] [Related]
18. The involvement of a cyclooxygenase 1 gene-derived protein in the antinociceptive action of paracetamol in mice. Ayoub SS; Colville-Nash PR; Willoughby DA; Botting RM Eur J Pharmacol; 2006 May; 538(1-3):57-65. PubMed ID: 16674937 [TBL] [Abstract][Full Text] [Related]
19. Combination of adenosine A1 and A2A receptor blocking agents induces caffeine-like locomotor stimulation in mice. Kuzmin A; Johansson B; Gimenez L; Ogren SO; Fredholm BB Eur Neuropsychopharmacol; 2006 Feb; 16(2):129-36. PubMed ID: 16054807 [TBL] [Abstract][Full Text] [Related]